Literature DB >> 30866938

Correction to: Pathway crosstalk perturbation network modeling for identification of connectivity changes induced by diabetic neuropathy and pioglitazone.

Guillermo de Anda-Jáuregui1,2, Kai Guo1, Brett A McGregor1, Eva L Feldman3, Junguk Hur4.   

Abstract

.

Entities:  

Year:  2019        PMID: 30866938      PMCID: PMC6416955          DOI: 10.1186/s12918-019-0707-x

Source DB:  PubMed          Journal:  BMC Syst Biol        ISSN: 1752-0509


× No keyword cloud information.
Correction to: BMC Systems Biology 20149 13:1 https://doi.org/10.1186/s12918-018-0674-7 Following publication of the original article [1], it was highlighted that the funding statement was not correct. This Correction article shows the correct and incorrect Funding section. Correct: The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK; 1R24082841 to E.L.F. and J.H.), the NIDDK Diabetic Complications Consortium Pilot Grant (DiaComp, https://diacomp.org/; DK076169; sub-award #25034–75 to J.H.), and University of North Dakota Post-Doc Pilot Grant (to K.G.), and the North Dakota EPSCoR through National Science Foundation grant #OIA-1355466 (to B.A.M.). Funding bodies had no role in the design, execution, or analysis of this work. Incorrect: The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK; 1R24082841 to E.L.F. and J.H.), the NIDDK Diabetic Complications Consortium Pilot Grant (DiaComp, https://diacomp.org/; DK076169; sub-award #25034–75 to J.H.), and University of North Dakota Post-Doc Pilot Grant (to K.G.). Funding bodies had no role in the design, execution, or analysis of this work.
  1 in total

1.  Pathway crosstalk perturbation network modeling for identification of connectivity changes induced by diabetic neuropathy and pioglitazone.

Authors:  Guillermo de Anda-Jáuregui; Kai Guo; Brett A McGregor; Eva L Feldman; Junguk Hur
Journal:  BMC Syst Biol       Date:  2019-01-07
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.